Skip to main content
Clinical Trials/NL-OMON33053
NL-OMON33053
Withdrawn
Phase 2

Study of Myocardial Recovery after Exercise Training in Heart Failure - SMARTEX-HF study

Academisch Medisch Centrum0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
decompensation
Sponsor
Academisch Medisch Centrum
Enrollment
20
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- congestive heart failure
  • \- LVEF \< 35%
  • \- NYHA class II\-III
  • \- minimum 3 months of optimal medical treatment

Exclusion Criteria

  • \- significant intercurrent illness last 6 weeks
  • \- known severe ventricular arrhythmia
  • \- significant ischemia
  • \- other heart disease that limits exercise tolerance

Outcomes

Primary Outcomes

Not specified

Similar Trials